Who can use Gilteritinib(Xospata)?

The specific medical condition the drug is approved to treat.

Who can use Gilteritinib(Xospata)?

XOSPATA is indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a confirmed FLT3 mutation. The presence of this mutation must be detected by an FDA-approved test prior to initiating treatment to identify the patient population most likely to benefit from this targeted therapy.